SlideShare a Scribd company logo
IMPORTANCE OF MOLECULAR
METHODS IN DIAGNOSIS OF
INFECTIOUS DISEASES – A Special
emphasis on Real Time PCR
Maj (Dr) Shilpi Gupta
Graded Specialist (Microbiology)
TOPIC FOR DISCUSSION
Introduction
Conventional Vs Molecular methods
Conventional PCR Vs Real Time PCR
Special Cases
INFECTIOUS DISEASES (LIST)
Bacterial
• Typhoid
• Cholera
• Tuberculosis
• Leprosy
• Tetanus
• Diphtheria
• Gonococcal
• Chlamydia
• Syphilis
• Leptospirosis
• Scrub typhus
• UTI
• Meningitis
• Bacterial dysentery
Viral
• Hepatitis A,B,C,D,E
• HIV
• Chicken pox
• Dengue
• Chikungunya
• Japanese
encephalitis (JE)
• H1N1
• SARS
• Ebola
• Nipah
• HPV
• Measles
• Encephalitis
Fungal
• Candidiasis
• Cryptococcosis
• Aspergillosis
• Penicilliosis
Parasitic
• Malaria
• Filaria
• Amoebiasis
• Leishmaniasis
• Kala azar
What are the available
options for Laboratory
Diagnosis?
LAB DIAGNOSIS OF INFECTIOUS DISEASES
MICROSCOPY
Gram Stain
ZN Stain
Fluorescence
stain
Electron
Microscopy
CULTURE
TECHNIQUES
Solid
Liquid
SEROLOGICAL
METHODS
Agglutination
Precipitation
ELISA
NUCLEIC ACID
AMPLIFICATION TEST
LAMP
PCR
Real Time PCR
OTHER
Biochemical
tests
TST/ Mantoux
test
Adenosine
Deaminase
(ADA)
Advantages of Molecular over conventional
methods
Molecular Conventional
Rapid (1h – 1 day) Days to month
More sensitive Less sensitive
More specific Less specific
Less laborious Laborious, requires manpower
Less chances of contamination Chances of contamination more
Quantification possible Qualitative
Conventional PCR Set up
REAL TIME PCR
Conventional PCR & Real Time PCR
Conventional PCR Real Time PCR
Semi-automated Totally automated
5-6 hrs to complete one test 1hrs or <1 hr for one test
Less sensitive, specific and reproducible
than REAL TIME
Most specific, sensitive , reliable and
reproducible
Requires sophisticated infrastructure Lesser space
POINT OF CARE TESTING (POCT)
Point-of-care testing (POCT): is defined as medical testing
at or near the site of patient care
• Simple, Automated & Easy to
read
• Independent power source
• Cost effective • Long shelf life reagents
• Microfluidic (less sample) • Short sample processing time
• Quantitative • High sensitivity and specificity
• Portable or near patient
diagnosis
• No need of skilled trained lab
technician
POCT (list)
Generation Methods Examples
First generation Rapid Detection tests (RDTs) Dengue, Chikungunya,
Hepatitis A, B, C, E
Second generation Cartridge based NAAT (CB NAAT) GeneXpert (MTB, H1N1, HIV,
HBV, HCV)
Third generation Hand held portable chip based
Real Time NAAT
TrueNat (HBV, HCV, Dengue,
Chikungunya, Malaria, HPV)
Pai, N.P
., et al. 2012, PLOS Medicine
Pai, N.P and Pai, M. Discovery medicine 2012
EVOLUTION OF NAAT: From reference lab
to Point-of-care
NAAT
• RT PCR
CB-NAAT
• Gene Xpert
• Xpert MTB/RIF
POCT
• Real time micro
system
13 Real Time PCR - Xpert MTB/RIF (Cepheid)
The Truelab™ Real Time micro PCR system
INDIGENOUS PRODUCT – TrueNAT (Molbio
Diagnostics)
ADVANTAGES OF TrueNAT over Xpert MTB/RIF
Xpert MTB/RIF TrueNAT
Method No step for removal of PCR
inhibitors
PCR inhibitors removed thus
increase positivity rate
Conditions for machine Non portable (bulky) system Potable
No battery backup Battery backup available
Strict temp conditions required Any temp
Senstivity & Specificity Slightly lesser Comparable or better
CASE SCENARIO
 27 y/o male, HIV-negative, presented to a hospital with 2 months of
cough
 CXR: “Diffuse micronodular pattern”
 Treated for Community Acquired Pneumonia and discharged
 Team did considered MTB
 Sputum AFB smear-negative
 Cultures pending
 No Sputum molecular method done
 Culture grew M. tuberculosis 1 month later
 Already hospitalized at another hospital in ICU
 Being treated for bacterial sepsis
 He not only tested positive for TB, but had also developed MDR-TB
 ATT is started, but patient passes away a few days later
Concerns in Diagnostics
 Medical diagnostics take time, are costly and often give
inconclusive results.
 Many doctors prefer to administer drugs on poor/average patients
on the basis of symptoms rather than recommending expensive
tests.
 By the time the disease is diagnosed, patients turn resistant to the
drugs or their disease worsens.
Real Time PCR is most
specific, sensitive, rapid, reliable,
reproducible, POCT and extremely
powerful method among all types of diagnostic
modalities
RECOMMENDED TESTS FOR PUL & EPTB
CONDITION FREQUENCY SPECIMEN RECOMMENDED TESTS REMARKS
Pulmonary TB 75% Sputum • Liquid culture (Gold
standard)
• Real Time PCR
• In MDR suspected
cases molecular
method should be 1st
choice
Tubercular
lymphadenitis
35-40% Lymph node
aspirate
• Liquid culture (~70%
positivity)
• Real Time PCR
Pleural TB 20% Pleural fluid • Biochemical analysis
• ADA is useful screening
• IGRA may be helpful
• Liquid culture (~80%
positivity)
• Real Time PCR has
low sensitivity
• Smear microscopy
lower sensitivity
RECOMMENDED TESTS FOR PUL & EPTB Contd..
CONDITION FREQUENCY SPECIMEN RECOMMENDED TESTS REMARKS
Genitourinary
TB
10-15% Urine • Culture (80% positivity)
• Real Time PCR (90%
positivity)
• Culture negative pyuria with
acidic urine
• 75% patients have abnormal
CXR
• 3 morning urine samples
collected (~100 ml)
Males Prostatic
secretion
• Culture (~40% positivity)
• Real Time PCR (~36%
positivity)
• Leucocyturia and hematuria
are seen in ~50%
Females Endometrial
biopsy tissue
Menstrual blood
Pelvic fluid
• Real Time PCR (~30%
positivity)
• Culture (~40% positivity)
• Patient present with infertility,
pelvic pain, menstrual
disorders
Potts disease 10% Pus drained
from abscess
Synovial fluid
Bone biopsy
• Culture
• Histology
• Radiological (CT MRI) reveals
characteristic lesions
RECOMMENDED TESTS FOR PUL & EPTB Contd..
CONDITION FREQUENCY SPECIMEN RECOMMENDED TESTS REMARKS
Tubercular
meningitis
5% CSF • Biochemical analysis
• Real Time PCR (~ 70%
positivity)
• Culture (~ 80 %
• Negative result does not
exclude diagnosis of
TBM
Tubercular
peritonitis
3.5% Ascitic fluid • Biochemical analysis
• Culture (low sensitivity)
• Peritoneal biopsy (by
laparoscopy) is often
needed to establish the
diagnosis
Tubercular
pericarditis
Very low Pericardial
fluid
• Biochemical analysis
• Culture (~ 70% positivity)
• ADA
• IFN Y assay
• Disease of elderly with
low TB prevalence
• Seen in HIV +ve
HEPATITIS B INFECTION
• Acute: Initial infection with the hepatitis B virus
Mild or Severe
• Chronic: Hepatitis B virus remains in the blood for more
than 6 months or for years CARRIERS
Recovery or Chronic hepatitis
(9 of 10) (1 of 10)
Why Chronic Hepatitis B is dangerous?
Chronic
Hepatitis B
Liver
cirrhosis
Liver
failure
Liver
cancer
HEPATITIS B
Algorithm for diagnosis of Hep B in Jaundice
patients
HBV
HBsAg
Reactive Non-reactive
IgM Anti HBc
Reactive
If HbsAg is Reactive and lgM anti HBc is Nonreactive: HBV positive
If lgM Anti HBc is Reactive and HBsAg is Nonreactive: HBV positive
If both Reactive: HBV positive
If both Non-reactive: HBV negative
Non-reactive
National Laboratory Guidelines for Testing of Viral Hepatitis,2018 MOHFW
Algorithm for diagnosis of Hep B in patients without
Jaundice
HBV
HBsAg
Reactive
Report: HBV
Positive
Non-
Report: HBV
Negative
National Laboratory Guidelines for Testing of Viral Hepatitis,2018 MOHFW
LAB DIAGNOSIS
Role of HBV DNA
 Most sensitive index of viral replication
 Better marker of level of viraemia as compared to HBeAg
 HBV detection based on Real Time PCR approach can detect
as few as 10² – 10³ genome copies.
 Useful in following the course of HBV replication in patients
with chronic hep B receiving antiviral chemotherapy
 Patients with HBV pre-core mutant are HBeAg negative and
HBV DNA positive
OCCULT HEPATITIS B INFECTION
 Occult Hepatitis B: Infection with detectable HBV DNA and
undetectable surface antigen (HBsAg) in blood (very low levels
(invariably <200 IU/mL).
 Most are also anti-HBc positive.
 HBV DNA amplification by Real Time PCR is a gold standard assay for
detection & quantification of Occult HBV infection.
2011, World J Gastroenterology
HEPATITIS C INFECTION
Fibrosis1
Chronic HCV
infection can lead to
the development of
fibrous scar tissue
within the liver
Fibrosis Cirrhosis Hepatocellular Carcinoma
(with cirrhosis)
Cirrhosis1,2
Over time, fibrosis can progress,
causing severe scarring of the
liver, restricted blood flow,
impaired liver function, and
eventually liver failure
HCC3
Cancer of the liver can
develop after years of
chronic HCV infection
Total
No.
Infected
(millions)
Diagnosed
Undiagnosed
2.7 to 5 Million1
75% Unaware of Infection
1.1 Million1
21% Unaware of Infection
~800,000 to 1.4 Million1
65% Unaware of Infection
HIV HBV HCV
4
3
2
1
0
Prevalence of Chronic Viral Infections
HCV is Nearly 4 Times as Prevalent as HIV and HBV
• A 2011 study estimated that as many as 5.2 million persons are
living with HCV in the United States2
HBV=hepatitis B virus; HCV=hepatitis C virus; HIV=human immunodeficiency virus.
1. Institute of Medicine. Washington, DC: The National Academies Press; 2010.
2. Chak E, et al. Liver Int. 2011;31(8):1090-1101.
3. Gish Hepatology 2015
Algorithm for diagnosis of Hep C in patients with or
without Jaundice
HCV
Anti HCV
Reactive
Report: *HCV Ab Positive
Non-reactive
Report: HCV Ab Negative
*Should be followed by testing for HCV RNA using NAT (RT-PCR) for confirmation
If HCV RNA is detected: current/active HCV infection
If HCV RNA is not detected: Past, resolved infection or false HCV antibody positivity
Method Screen Confirm
Duration
of therapy
Assessing
treatment
response
HCV antibody test
(ELISA)
X
PCR: HCV genotype X
Real Time PCR:
HCV RNA
X X
Australian Government National Hepatitis C Testing Policy 2007. Available at: http://www.health.gov.au
Mosquito borne illness
What causes Malaria?
 Malaria is caused by Plasmodium of which 4 species infect humans.
-P. vivax
-P. ovale
-P. malariae
-P. falciparum :causes the most severe form of malaria
Cerebral malaria
Acute renal failure
Acute respiratory distress syndrome (ARDS)
Severe anaemia (Hb < 5g%)
Hemoglobinuria
Hypotension, Shock
Hyperpyrexia
Hemolysis
DIAGNOSIS
•Fever, Chills,
Headache,
Malaise, Vomiting,
Diarrhea, jaundice,
Body & Joint Pain
CLINICAL
• Technical and expert skill
required
• Early infection parasite
not detected
• Qualitative
MICROSCOPY
• False negative results
• overall sensitivity of <
81%.
• Cross reactivity with
rheumatoid factor
RDT RT PCR
• Most specific,
sensitive , reliable
and reproducible
• Exact quantification
of DNA in sample
DENGUE FEVER AND CHIKUNGUNYA
LAB DIAGNOSIS
Method Detection Test
Antigen
detection
Detect the NS1 antigen RDT, ELISA, Real Time PCR
Antibody
detection
Detect IgM and IgG
antibodies
RDT, ELISA
Viral isolation Grows virus Viral culture
LAB DIAGNOSIS
 Virus isolation
 Must only be carried in Level-3 laboratories
 Results can take between 1-2 weeks.
 Real Time PCR
 Rapid
 Reliable
 Specific
Human Papilloma Virus (HPV)
 More than 100 types of HPV, of which atleast 14 are cancer
causing.
 Two HPV types (16 and 18) cause 70% of cervical cancers
and pre-cancerous cervical lesions.
 Cervical cancer is the second most common cancer in
women in developing countries.
PREVENTION
PRIMARY SECONDARY TERTIARY
Girls 9-14 yrs Women 30 years old or older All women as needed
HPV vaccination Screen and treat Treatment of invasive cancer
at any age
Health and sex education 1. HPV testing for high risk
HPV types – POCT
2. Visual inspection with
Acetic acid (VIA)
3. PAP test and liquid based
cytology (LBC)
Surgery
Radiotherapy
Chemotherapy
Palliative
Condom promotion Followed by treatment
Male circumcision
abnormal cells in micropscope
CxCa Prevention (screening)
When positive triage, diagnosis, therapy
1) PAP smear
2) HPV Test
High-risk HPV16,18,31,33,…
Low-risk HPV6, 11, 42,…..
Take Home Message
 Conventional Microbiological diagnostic methods are time taking
and inconclusive at times
 Advance Molecular methods are rapid, specific and most reliable in
current scenario
 To date Real Time PCR is the only available method for diagnosis in
certain conditions
THANK YOU

More Related Content

What's hot

Congenital Viral Infection
Congenital Viral InfectionCongenital Viral Infection
Congenital Viral InfectionDang Thanh Tuan
 
Identification of antibiotic resistance genes in Klebsiella pneumoniae isolat...
Identification of antibiotic resistance genes in Klebsiella pneumoniae isolat...Identification of antibiotic resistance genes in Klebsiella pneumoniae isolat...
Identification of antibiotic resistance genes in Klebsiella pneumoniae isolat...
QIAGEN
 
Hpv Sample Collection Procedure
Hpv Sample Collection ProcedureHpv Sample Collection Procedure
Hpv Sample Collection Proceduredrsubir
 
Lab diagnosis hiv
Lab diagnosis hivLab diagnosis hiv
Lab diagnosis hiv
Upama Sishan
 
Multiplex PCR and its Applications
Multiplex PCR and its ApplicationsMultiplex PCR and its Applications
Multiplex PCR and its Applications
Nagendra P
 
Gene Xpert & Advances
Gene Xpert & AdvancesGene Xpert & Advances
Gene Xpert & Advances
AIIMS, New Delhi, India
 
ESBL Detection
ESBL DetectionESBL Detection
ESBL Detection
Dr. Samira Fattah
 
Diagnostic Medical Microbiology - Traditional and Modern approach
Diagnostic Medical Microbiology - Traditional and Modern approachDiagnostic Medical Microbiology - Traditional and Modern approach
Diagnostic Medical Microbiology - Traditional and Modern approach
Chhaya Sawant
 
Lect 2 laboratory diagnosis of viral infections
Lect 2 laboratory diagnosis of viral infectionsLect 2 laboratory diagnosis of viral infections
Lect 2 laboratory diagnosis of viral infections
Dr. Riaz Ahmad Bhutta
 
Hiv lab diagnosis
Hiv lab diagnosis Hiv lab diagnosis
Hiv lab diagnosis
Mostafa Mahmoud
 
Significant bacteriuria
Significant bacteriuriaSignificant bacteriuria
Significant bacteriuria
Dinesh Kumar
 
Lecture 7-c-reactive protein
Lecture 7-c-reactive proteinLecture 7-c-reactive protein
Lecture 7-c-reactive protein
said warsame
 
SARS-CoV-2 Rapid ANTIGEN TEST PPT
SARS-CoV-2 Rapid ANTIGEN  TEST PPTSARS-CoV-2 Rapid ANTIGEN  TEST PPT
SARS-CoV-2 Rapid ANTIGEN TEST PPT
Vindhya Vidhyadharan
 
laboratory diagnosis of viral hepatitis (B & C)
laboratory diagnosis of viral hepatitis (B & C)laboratory diagnosis of viral hepatitis (B & C)
laboratory diagnosis of viral hepatitis (B & C)
PathKind Labs
 
Xpert MTB RIF
Xpert MTB RIFXpert MTB RIF
Xpert MTB RIF
Dr. Rajat Prakash
 
Hepatitis B Virus
Hepatitis B VirusHepatitis B Virus
Hepatitis B Virus
Dr. Rakesh Prasad Sah
 
Methods of Laboratory diagnosis (genotypic detection) of HIV
Methods of Laboratory diagnosis (genotypic detection) of HIVMethods of Laboratory diagnosis (genotypic detection) of HIV
Methods of Laboratory diagnosis (genotypic detection) of HIV
drakmane
 
Widal test
Widal testWidal test
Widal test
deepak_kumarjha
 
Overview of covid 19 testing by rt-pcr
Overview of covid 19 testing by rt-pcrOverview of covid 19 testing by rt-pcr
Overview of covid 19 testing by rt-pcr
RipuDas
 
Hcv - immune evasion mechanisms
Hcv - immune evasion mechanismsHcv - immune evasion mechanisms
Hcv - immune evasion mechanisms
Marina Ibrahim
 

What's hot (20)

Congenital Viral Infection
Congenital Viral InfectionCongenital Viral Infection
Congenital Viral Infection
 
Identification of antibiotic resistance genes in Klebsiella pneumoniae isolat...
Identification of antibiotic resistance genes in Klebsiella pneumoniae isolat...Identification of antibiotic resistance genes in Klebsiella pneumoniae isolat...
Identification of antibiotic resistance genes in Klebsiella pneumoniae isolat...
 
Hpv Sample Collection Procedure
Hpv Sample Collection ProcedureHpv Sample Collection Procedure
Hpv Sample Collection Procedure
 
Lab diagnosis hiv
Lab diagnosis hivLab diagnosis hiv
Lab diagnosis hiv
 
Multiplex PCR and its Applications
Multiplex PCR and its ApplicationsMultiplex PCR and its Applications
Multiplex PCR and its Applications
 
Gene Xpert & Advances
Gene Xpert & AdvancesGene Xpert & Advances
Gene Xpert & Advances
 
ESBL Detection
ESBL DetectionESBL Detection
ESBL Detection
 
Diagnostic Medical Microbiology - Traditional and Modern approach
Diagnostic Medical Microbiology - Traditional and Modern approachDiagnostic Medical Microbiology - Traditional and Modern approach
Diagnostic Medical Microbiology - Traditional and Modern approach
 
Lect 2 laboratory diagnosis of viral infections
Lect 2 laboratory diagnosis of viral infectionsLect 2 laboratory diagnosis of viral infections
Lect 2 laboratory diagnosis of viral infections
 
Hiv lab diagnosis
Hiv lab diagnosis Hiv lab diagnosis
Hiv lab diagnosis
 
Significant bacteriuria
Significant bacteriuriaSignificant bacteriuria
Significant bacteriuria
 
Lecture 7-c-reactive protein
Lecture 7-c-reactive proteinLecture 7-c-reactive protein
Lecture 7-c-reactive protein
 
SARS-CoV-2 Rapid ANTIGEN TEST PPT
SARS-CoV-2 Rapid ANTIGEN  TEST PPTSARS-CoV-2 Rapid ANTIGEN  TEST PPT
SARS-CoV-2 Rapid ANTIGEN TEST PPT
 
laboratory diagnosis of viral hepatitis (B & C)
laboratory diagnosis of viral hepatitis (B & C)laboratory diagnosis of viral hepatitis (B & C)
laboratory diagnosis of viral hepatitis (B & C)
 
Xpert MTB RIF
Xpert MTB RIFXpert MTB RIF
Xpert MTB RIF
 
Hepatitis B Virus
Hepatitis B VirusHepatitis B Virus
Hepatitis B Virus
 
Methods of Laboratory diagnosis (genotypic detection) of HIV
Methods of Laboratory diagnosis (genotypic detection) of HIVMethods of Laboratory diagnosis (genotypic detection) of HIV
Methods of Laboratory diagnosis (genotypic detection) of HIV
 
Widal test
Widal testWidal test
Widal test
 
Overview of covid 19 testing by rt-pcr
Overview of covid 19 testing by rt-pcrOverview of covid 19 testing by rt-pcr
Overview of covid 19 testing by rt-pcr
 
Hcv - immune evasion mechanisms
Hcv - immune evasion mechanismsHcv - immune evasion mechanisms
Hcv - immune evasion mechanisms
 

Similar to Importance of real time pcr in diagnosis of infectious diseases

PrecriptionPiont - 2.ppt
PrecriptionPiont - 2.pptPrecriptionPiont - 2.ppt
PrecriptionPiont - 2.ppt
RajKumarSingha5
 
Hepatitis c virus in blood transfusion
Hepatitis c virus in blood transfusionHepatitis c virus in blood transfusion
Hepatitis c virus in blood transfusion
SUJAY BHOWMIK
 
Tb sure ultra short july 2019
Tb sure ultra short july 2019Tb sure ultra short july 2019
Tb sure ultra short july 2019
PathKind Labs
 
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptxviral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
PathKind Labs
 
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptxwhat is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
PathKind Labs
 
Presentation
PresentationPresentation
Presentation
drsalwa22000
 
Genital Tuberculosis- Newer trends in the diagnostic modalities
Genital Tuberculosis- Newer trends in the diagnostic modalitiesGenital Tuberculosis- Newer trends in the diagnostic modalities
Genital Tuberculosis- Newer trends in the diagnostic modalities
Dr Anusha Rao P
 
HEPATITIS part 2.pptx
HEPATITIS part 2.pptxHEPATITIS part 2.pptx
HEPATITIS part 2.pptx
JazeelaMohamedSiddiq
 
Detection of HIV-TB co infection New approaches
Detection of HIV-TB co infectionNew approachesDetection of HIV-TB co infectionNew approaches
Detection of HIV-TB co infection New approaches
Sri Lanka College of Sexual Health and HIV Medicine
 
The role of the clinical lab in diagnosis of hiv
The role of the clinical lab in diagnosis of hivThe role of the clinical lab in diagnosis of hiv
The role of the clinical lab in diagnosis of hiv
Ayman Allam
 
Cbnaat ppt by Dr. Samrat Abhishek
Cbnaat ppt by Dr. Samrat AbhishekCbnaat ppt by Dr. Samrat Abhishek
Cbnaat ppt by Dr. Samrat Abhishek
Samrat Abhishek
 
Needle stick Injury
Needle stick Injury Needle stick Injury
Needle stick Injury
Dr. Kanwal Deep Singh Lyall
 
Viral hepatitis- At a glance.ppt
Viral hepatitis- At a glance.pptViral hepatitis- At a glance.ppt
Viral hepatitis- At a glance.ppt
Suman Baral
 
Molecular assay in tuberculosis.pptx
Molecular assay in tuberculosis.pptxMolecular assay in tuberculosis.pptx
Molecular assay in tuberculosis.pptx
yogeshtomar32
 
Assessment of serum lipid profile in patients with chronic hepatitis c
Assessment of serum lipid profile in patients with chronic hepatitis cAssessment of serum lipid profile in patients with chronic hepatitis c
Assessment of serum lipid profile in patients with chronic hepatitis c
Tanveer00786
 
Nucliec Acid Testing in Blood and solid organ Donor Screening by dr umair
Nucliec Acid Testing in Blood and solid organ Donor Screening by dr umairNucliec Acid Testing in Blood and solid organ Donor Screening by dr umair
Nucliec Acid Testing in Blood and solid organ Donor Screening by dr umair
Dr. Umair Manghrio
 
Hiv in pregnancy by DR.Paramanantham
Hiv in pregnancy by DR.ParamananthamHiv in pregnancy by DR.Paramanantham
Hiv in pregnancy by DR.Paramanantham
PAEDIATRICSDEPT
 
Hepatitisfull presenta and full all .pptx
Hepatitisfull presenta and full all .pptxHepatitisfull presenta and full all .pptx
Hepatitisfull presenta and full all .pptx
MuhammadAfrazNuman
 
Hepatitis C:Diagnosis and management.pdf
Hepatitis C:Diagnosis and management.pdfHepatitis C:Diagnosis and management.pdf
Hepatitis C:Diagnosis and management.pdf
PrajnyaTwinkle
 

Similar to Importance of real time pcr in diagnosis of infectious diseases (20)

Hcv
HcvHcv
Hcv
 
PrecriptionPiont - 2.ppt
PrecriptionPiont - 2.pptPrecriptionPiont - 2.ppt
PrecriptionPiont - 2.ppt
 
Hepatitis c virus in blood transfusion
Hepatitis c virus in blood transfusionHepatitis c virus in blood transfusion
Hepatitis c virus in blood transfusion
 
Tb sure ultra short july 2019
Tb sure ultra short july 2019Tb sure ultra short july 2019
Tb sure ultra short july 2019
 
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptxviral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
 
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptxwhat is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
 
Presentation
PresentationPresentation
Presentation
 
Genital Tuberculosis- Newer trends in the diagnostic modalities
Genital Tuberculosis- Newer trends in the diagnostic modalitiesGenital Tuberculosis- Newer trends in the diagnostic modalities
Genital Tuberculosis- Newer trends in the diagnostic modalities
 
HEPATITIS part 2.pptx
HEPATITIS part 2.pptxHEPATITIS part 2.pptx
HEPATITIS part 2.pptx
 
Detection of HIV-TB co infection New approaches
Detection of HIV-TB co infectionNew approachesDetection of HIV-TB co infectionNew approaches
Detection of HIV-TB co infection New approaches
 
The role of the clinical lab in diagnosis of hiv
The role of the clinical lab in diagnosis of hivThe role of the clinical lab in diagnosis of hiv
The role of the clinical lab in diagnosis of hiv
 
Cbnaat ppt by Dr. Samrat Abhishek
Cbnaat ppt by Dr. Samrat AbhishekCbnaat ppt by Dr. Samrat Abhishek
Cbnaat ppt by Dr. Samrat Abhishek
 
Needle stick Injury
Needle stick Injury Needle stick Injury
Needle stick Injury
 
Viral hepatitis- At a glance.ppt
Viral hepatitis- At a glance.pptViral hepatitis- At a glance.ppt
Viral hepatitis- At a glance.ppt
 
Molecular assay in tuberculosis.pptx
Molecular assay in tuberculosis.pptxMolecular assay in tuberculosis.pptx
Molecular assay in tuberculosis.pptx
 
Assessment of serum lipid profile in patients with chronic hepatitis c
Assessment of serum lipid profile in patients with chronic hepatitis cAssessment of serum lipid profile in patients with chronic hepatitis c
Assessment of serum lipid profile in patients with chronic hepatitis c
 
Nucliec Acid Testing in Blood and solid organ Donor Screening by dr umair
Nucliec Acid Testing in Blood and solid organ Donor Screening by dr umairNucliec Acid Testing in Blood and solid organ Donor Screening by dr umair
Nucliec Acid Testing in Blood and solid organ Donor Screening by dr umair
 
Hiv in pregnancy by DR.Paramanantham
Hiv in pregnancy by DR.ParamananthamHiv in pregnancy by DR.Paramanantham
Hiv in pregnancy by DR.Paramanantham
 
Hepatitisfull presenta and full all .pptx
Hepatitisfull presenta and full all .pptxHepatitisfull presenta and full all .pptx
Hepatitisfull presenta and full all .pptx
 
Hepatitis C:Diagnosis and management.pdf
Hepatitis C:Diagnosis and management.pdfHepatitis C:Diagnosis and management.pdf
Hepatitis C:Diagnosis and management.pdf
 

Recently uploaded

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 

Recently uploaded (20)

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 

Importance of real time pcr in diagnosis of infectious diseases

  • 1. IMPORTANCE OF MOLECULAR METHODS IN DIAGNOSIS OF INFECTIOUS DISEASES – A Special emphasis on Real Time PCR Maj (Dr) Shilpi Gupta Graded Specialist (Microbiology)
  • 2. TOPIC FOR DISCUSSION Introduction Conventional Vs Molecular methods Conventional PCR Vs Real Time PCR Special Cases
  • 3. INFECTIOUS DISEASES (LIST) Bacterial • Typhoid • Cholera • Tuberculosis • Leprosy • Tetanus • Diphtheria • Gonococcal • Chlamydia • Syphilis • Leptospirosis • Scrub typhus • UTI • Meningitis • Bacterial dysentery Viral • Hepatitis A,B,C,D,E • HIV • Chicken pox • Dengue • Chikungunya • Japanese encephalitis (JE) • H1N1 • SARS • Ebola • Nipah • HPV • Measles • Encephalitis Fungal • Candidiasis • Cryptococcosis • Aspergillosis • Penicilliosis Parasitic • Malaria • Filaria • Amoebiasis • Leishmaniasis • Kala azar
  • 4. What are the available options for Laboratory Diagnosis?
  • 5. LAB DIAGNOSIS OF INFECTIOUS DISEASES MICROSCOPY Gram Stain ZN Stain Fluorescence stain Electron Microscopy CULTURE TECHNIQUES Solid Liquid SEROLOGICAL METHODS Agglutination Precipitation ELISA NUCLEIC ACID AMPLIFICATION TEST LAMP PCR Real Time PCR OTHER Biochemical tests TST/ Mantoux test Adenosine Deaminase (ADA)
  • 6. Advantages of Molecular over conventional methods Molecular Conventional Rapid (1h – 1 day) Days to month More sensitive Less sensitive More specific Less specific Less laborious Laborious, requires manpower Less chances of contamination Chances of contamination more Quantification possible Qualitative
  • 7. Conventional PCR Set up REAL TIME PCR
  • 8. Conventional PCR & Real Time PCR Conventional PCR Real Time PCR Semi-automated Totally automated 5-6 hrs to complete one test 1hrs or <1 hr for one test Less sensitive, specific and reproducible than REAL TIME Most specific, sensitive , reliable and reproducible Requires sophisticated infrastructure Lesser space
  • 9.
  • 10. POINT OF CARE TESTING (POCT) Point-of-care testing (POCT): is defined as medical testing at or near the site of patient care • Simple, Automated & Easy to read • Independent power source • Cost effective • Long shelf life reagents • Microfluidic (less sample) • Short sample processing time • Quantitative • High sensitivity and specificity • Portable or near patient diagnosis • No need of skilled trained lab technician
  • 11. POCT (list) Generation Methods Examples First generation Rapid Detection tests (RDTs) Dengue, Chikungunya, Hepatitis A, B, C, E Second generation Cartridge based NAAT (CB NAAT) GeneXpert (MTB, H1N1, HIV, HBV, HCV) Third generation Hand held portable chip based Real Time NAAT TrueNat (HBV, HCV, Dengue, Chikungunya, Malaria, HPV) Pai, N.P ., et al. 2012, PLOS Medicine Pai, N.P and Pai, M. Discovery medicine 2012
  • 12. EVOLUTION OF NAAT: From reference lab to Point-of-care NAAT • RT PCR CB-NAAT • Gene Xpert • Xpert MTB/RIF POCT • Real time micro system
  • 13. 13 Real Time PCR - Xpert MTB/RIF (Cepheid)
  • 14. The Truelab™ Real Time micro PCR system
  • 15. INDIGENOUS PRODUCT – TrueNAT (Molbio Diagnostics)
  • 16. ADVANTAGES OF TrueNAT over Xpert MTB/RIF Xpert MTB/RIF TrueNAT Method No step for removal of PCR inhibitors PCR inhibitors removed thus increase positivity rate Conditions for machine Non portable (bulky) system Potable No battery backup Battery backup available Strict temp conditions required Any temp Senstivity & Specificity Slightly lesser Comparable or better
  • 17. CASE SCENARIO  27 y/o male, HIV-negative, presented to a hospital with 2 months of cough  CXR: “Diffuse micronodular pattern”  Treated for Community Acquired Pneumonia and discharged  Team did considered MTB  Sputum AFB smear-negative  Cultures pending  No Sputum molecular method done  Culture grew M. tuberculosis 1 month later  Already hospitalized at another hospital in ICU  Being treated for bacterial sepsis  He not only tested positive for TB, but had also developed MDR-TB  ATT is started, but patient passes away a few days later
  • 18. Concerns in Diagnostics  Medical diagnostics take time, are costly and often give inconclusive results.  Many doctors prefer to administer drugs on poor/average patients on the basis of symptoms rather than recommending expensive tests.  By the time the disease is diagnosed, patients turn resistant to the drugs or their disease worsens.
  • 19. Real Time PCR is most specific, sensitive, rapid, reliable, reproducible, POCT and extremely powerful method among all types of diagnostic modalities
  • 20. RECOMMENDED TESTS FOR PUL & EPTB CONDITION FREQUENCY SPECIMEN RECOMMENDED TESTS REMARKS Pulmonary TB 75% Sputum • Liquid culture (Gold standard) • Real Time PCR • In MDR suspected cases molecular method should be 1st choice Tubercular lymphadenitis 35-40% Lymph node aspirate • Liquid culture (~70% positivity) • Real Time PCR Pleural TB 20% Pleural fluid • Biochemical analysis • ADA is useful screening • IGRA may be helpful • Liquid culture (~80% positivity) • Real Time PCR has low sensitivity • Smear microscopy lower sensitivity
  • 21. RECOMMENDED TESTS FOR PUL & EPTB Contd.. CONDITION FREQUENCY SPECIMEN RECOMMENDED TESTS REMARKS Genitourinary TB 10-15% Urine • Culture (80% positivity) • Real Time PCR (90% positivity) • Culture negative pyuria with acidic urine • 75% patients have abnormal CXR • 3 morning urine samples collected (~100 ml) Males Prostatic secretion • Culture (~40% positivity) • Real Time PCR (~36% positivity) • Leucocyturia and hematuria are seen in ~50% Females Endometrial biopsy tissue Menstrual blood Pelvic fluid • Real Time PCR (~30% positivity) • Culture (~40% positivity) • Patient present with infertility, pelvic pain, menstrual disorders Potts disease 10% Pus drained from abscess Synovial fluid Bone biopsy • Culture • Histology • Radiological (CT MRI) reveals characteristic lesions
  • 22. RECOMMENDED TESTS FOR PUL & EPTB Contd.. CONDITION FREQUENCY SPECIMEN RECOMMENDED TESTS REMARKS Tubercular meningitis 5% CSF • Biochemical analysis • Real Time PCR (~ 70% positivity) • Culture (~ 80 % • Negative result does not exclude diagnosis of TBM Tubercular peritonitis 3.5% Ascitic fluid • Biochemical analysis • Culture (low sensitivity) • Peritoneal biopsy (by laparoscopy) is often needed to establish the diagnosis Tubercular pericarditis Very low Pericardial fluid • Biochemical analysis • Culture (~ 70% positivity) • ADA • IFN Y assay • Disease of elderly with low TB prevalence • Seen in HIV +ve
  • 23. HEPATITIS B INFECTION • Acute: Initial infection with the hepatitis B virus Mild or Severe • Chronic: Hepatitis B virus remains in the blood for more than 6 months or for years CARRIERS Recovery or Chronic hepatitis (9 of 10) (1 of 10) Why Chronic Hepatitis B is dangerous? Chronic Hepatitis B Liver cirrhosis Liver failure Liver cancer
  • 25. Algorithm for diagnosis of Hep B in Jaundice patients HBV HBsAg Reactive Non-reactive IgM Anti HBc Reactive If HbsAg is Reactive and lgM anti HBc is Nonreactive: HBV positive If lgM Anti HBc is Reactive and HBsAg is Nonreactive: HBV positive If both Reactive: HBV positive If both Non-reactive: HBV negative Non-reactive National Laboratory Guidelines for Testing of Viral Hepatitis,2018 MOHFW
  • 26. Algorithm for diagnosis of Hep B in patients without Jaundice HBV HBsAg Reactive Report: HBV Positive Non- Report: HBV Negative National Laboratory Guidelines for Testing of Viral Hepatitis,2018 MOHFW
  • 28. Role of HBV DNA  Most sensitive index of viral replication  Better marker of level of viraemia as compared to HBeAg  HBV detection based on Real Time PCR approach can detect as few as 10² – 10³ genome copies.  Useful in following the course of HBV replication in patients with chronic hep B receiving antiviral chemotherapy  Patients with HBV pre-core mutant are HBeAg negative and HBV DNA positive
  • 29. OCCULT HEPATITIS B INFECTION  Occult Hepatitis B: Infection with detectable HBV DNA and undetectable surface antigen (HBsAg) in blood (very low levels (invariably <200 IU/mL).  Most are also anti-HBc positive.  HBV DNA amplification by Real Time PCR is a gold standard assay for detection & quantification of Occult HBV infection. 2011, World J Gastroenterology
  • 30.
  • 31. HEPATITIS C INFECTION Fibrosis1 Chronic HCV infection can lead to the development of fibrous scar tissue within the liver Fibrosis Cirrhosis Hepatocellular Carcinoma (with cirrhosis) Cirrhosis1,2 Over time, fibrosis can progress, causing severe scarring of the liver, restricted blood flow, impaired liver function, and eventually liver failure HCC3 Cancer of the liver can develop after years of chronic HCV infection
  • 32. Total No. Infected (millions) Diagnosed Undiagnosed 2.7 to 5 Million1 75% Unaware of Infection 1.1 Million1 21% Unaware of Infection ~800,000 to 1.4 Million1 65% Unaware of Infection HIV HBV HCV 4 3 2 1 0 Prevalence of Chronic Viral Infections HCV is Nearly 4 Times as Prevalent as HIV and HBV • A 2011 study estimated that as many as 5.2 million persons are living with HCV in the United States2 HBV=hepatitis B virus; HCV=hepatitis C virus; HIV=human immunodeficiency virus. 1. Institute of Medicine. Washington, DC: The National Academies Press; 2010. 2. Chak E, et al. Liver Int. 2011;31(8):1090-1101. 3. Gish Hepatology 2015
  • 33. Algorithm for diagnosis of Hep C in patients with or without Jaundice HCV Anti HCV Reactive Report: *HCV Ab Positive Non-reactive Report: HCV Ab Negative *Should be followed by testing for HCV RNA using NAT (RT-PCR) for confirmation If HCV RNA is detected: current/active HCV infection If HCV RNA is not detected: Past, resolved infection or false HCV antibody positivity
  • 34. Method Screen Confirm Duration of therapy Assessing treatment response HCV antibody test (ELISA) X PCR: HCV genotype X Real Time PCR: HCV RNA X X Australian Government National Hepatitis C Testing Policy 2007. Available at: http://www.health.gov.au
  • 36. What causes Malaria?  Malaria is caused by Plasmodium of which 4 species infect humans. -P. vivax -P. ovale -P. malariae -P. falciparum :causes the most severe form of malaria Cerebral malaria Acute renal failure Acute respiratory distress syndrome (ARDS) Severe anaemia (Hb < 5g%) Hemoglobinuria Hypotension, Shock Hyperpyrexia Hemolysis
  • 37. DIAGNOSIS •Fever, Chills, Headache, Malaise, Vomiting, Diarrhea, jaundice, Body & Joint Pain CLINICAL • Technical and expert skill required • Early infection parasite not detected • Qualitative MICROSCOPY • False negative results • overall sensitivity of < 81%. • Cross reactivity with rheumatoid factor RDT RT PCR • Most specific, sensitive , reliable and reproducible • Exact quantification of DNA in sample
  • 38.
  • 39. DENGUE FEVER AND CHIKUNGUNYA
  • 40. LAB DIAGNOSIS Method Detection Test Antigen detection Detect the NS1 antigen RDT, ELISA, Real Time PCR Antibody detection Detect IgM and IgG antibodies RDT, ELISA Viral isolation Grows virus Viral culture
  • 41.
  • 42.
  • 43. LAB DIAGNOSIS  Virus isolation  Must only be carried in Level-3 laboratories  Results can take between 1-2 weeks.  Real Time PCR  Rapid  Reliable  Specific
  • 44. Human Papilloma Virus (HPV)  More than 100 types of HPV, of which atleast 14 are cancer causing.  Two HPV types (16 and 18) cause 70% of cervical cancers and pre-cancerous cervical lesions.  Cervical cancer is the second most common cancer in women in developing countries.
  • 45. PREVENTION PRIMARY SECONDARY TERTIARY Girls 9-14 yrs Women 30 years old or older All women as needed HPV vaccination Screen and treat Treatment of invasive cancer at any age Health and sex education 1. HPV testing for high risk HPV types – POCT 2. Visual inspection with Acetic acid (VIA) 3. PAP test and liquid based cytology (LBC) Surgery Radiotherapy Chemotherapy Palliative Condom promotion Followed by treatment Male circumcision
  • 46. abnormal cells in micropscope CxCa Prevention (screening) When positive triage, diagnosis, therapy 1) PAP smear 2) HPV Test High-risk HPV16,18,31,33,… Low-risk HPV6, 11, 42,…..
  • 47. Take Home Message  Conventional Microbiological diagnostic methods are time taking and inconclusive at times  Advance Molecular methods are rapid, specific and most reliable in current scenario  To date Real Time PCR is the only available method for diagnosis in certain conditions

Editor's Notes

  1. Slide 23. The role of testing in diagnosis and treatment The HCV antibody test (Enzyme Immune Assay; EIA), which is used to detect the presence of anti-HCV, is the usual initial test for patients with clinical liver disease and is also acceptable for screening at-risk patients. To confirm the diagnosis, testing for serum HCV ribonucleic acid (RNA) by sensitive polymerase chain reaction (PCR) amplification is recommended. Prior to initiating treatment in patients infected with chronic hepatitis C, it is important to determine the patient’s baseline viral load with a quantitative assay as well as their HCV genotype. HCV genotype determines the length of therapy. While on treatment, patients’ progress can be monitored by determining the presence of HCV RNA, with a quantitative PCR assay. At the end of treatment and at follow-up a qualitative test will confirm the absence of HCV replication. 
  2. 47